<DOC>
	<DOCNO>NCT00713440</DOCNO>
	<brief_summary>The purpose study evaluate whether reduced incretin effect paradoxical glucagon response oral glucose ingestion isoglycaemic iv glucose infusion observe patient type 2 diabetes cause ( non-inducible lean healthy subject without family history diabetes ) consequence ( inducible ) diabetic state .</brief_summary>
	<brief_title>Incretin Physiology Associated With Steroid Hormone Treatment</brief_title>
	<detailed_description>The incretin effect severely reduce patient type 2 diabetes . This pathophysiological trait accompany almost abolish insulinotropic effect incretin hormone glucose-dependent insulinotropic polypeptide ( GIP ) reduce insulinotropic potency incretin hormone glucagon-like peptide-1 ( GLP-1 ) . Furthermore , recent study suggest hypersecretion glucagon oral glucose ingestion , oppose normal suppression glucagon isoglycaemic intravenous ( iv ) administer glucose , attenuate incretin effect patient type 2 diabetes . However , remain unclear whether severely reduce incretin effect accompany pathophysiological trait characterize patient type 2 diabetes induce temporarily healthy subject short period glucose homeostatic dysregulation . In study incretin effect measure use 50-g oral glucose tolerance test isoglycaemic iv glucose infusion meal test 10 healthy Caucasian subject without family history diabetes dysregulation glucose homeostasis use high calorie diet , physical inactivity administration adrenocortical steroid</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Gastric Inhibitory Polypeptide</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Incretins</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Caucasians without Type 2 Type 1 Diabetes Normal OGTT ( 75 g glucose ) accord WHO criteria Normal hemoglobin Normal blood pressure Liver disease Kidney disease Relatives ( parents/siblings ) type 2 diabetes Pregnancy Contraindications treatment adrenocortical steroid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Incretin Effect</keyword>
	<keyword>Steroids</keyword>
	<keyword>Glucagon-Like Peptide 1</keyword>
	<keyword>Gastric Inhibitory Peptide</keyword>
	<keyword>Glucose-dependent Insulinotropic Polypeptide</keyword>
	<keyword>Insulin</keyword>
	<keyword>C-peptide</keyword>
	<keyword>Glucagon</keyword>
</DOC>